Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL
- Address
- Avinguda De La Gran Via De L'hospitalet 199, 08908 L'hospitalet De Llobregat, Spain
Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL
IDIBELL is a leading biomedical research institute conducting innovative oncology trials with a focus on personalized cancer treatment approaches. The center specializes in advanced gastrointestinal cancer research, utilizing cutting-edge biomarkers to optimize therapeutic strategies and improve patient outcomes.
- Precision oncology using circulating tumor DNA (ctDNA) as a biomarker for treatment response
- Adjuvant chemotherapy optimization in colorectal cancer
- Comparative effectiveness studies of intensive versus standard treatment regimens
The institute's research portfolio demonstrates expertise in localized colon cancer management, particularly in stage II-III disease. Their innovative approach combines liquid biopsy technology with randomized controlled trials to evaluate intensive chemotherapy protocols such as FOLFOXIRI against conventional regimens like CAPOX, aiming to identify patients who may benefit most from treatment intensification based on molecular biomarkers.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Intensive Versus Standard Adjuvant Chemotherapy with FOLFOXIRI and CAPOX in Stage II-III Localized Colon Cancer with Circulating Tumor DNA | Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA | Phase II | Not Recruiting | Jan 2025 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| ADMILPARANT | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.